December 24, 2008
BD to Present at Investor Healthcare Conferences |
December 04, 2008
BD Receives FDA Approval for the BD FocalPoint(TM) GS Imaging System to Enhance the Detection of Cervical Cancer |
November 25, 2008
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases |
November 05, 2008
BD Announces Executive Appointments of President and Chief Financial Officer |
November 05, 2008
BD Announces Results for Fourth Fiscal Quarter and Full Year |
November 03, 2008
BD to Present at Investor Healthcare Conferences |
October 02, 2008
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call |
September 25, 2008
Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital |
August 27, 2008
BD to Present at Investor Healthcare Conferences |
July 24, 2008
BD Announces Results for Third Fiscal Quarter |
July 22, 2008
BD Board Declares Dividend |
July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections |
June 24, 2008
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call |
June 03, 2008
BD to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference |
May 20, 2008
BD Board Declares Dividend |
May 13, 2008
BD Announces Acquisition of Cytopeia |
May 07, 2008
BD to Present at Investor Healthcare Conferences |
April 23, 2008
BD Announces Results for Second Fiscal Quarter |
April 23, 2008
BD to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference |
March 27, 2008
BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana |
March 26, 2008
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call |
March 26, 2008
BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference |
March 18, 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors |
March 17, 2008
BD GeneOhm(TM) MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates |
March 07, 2008
BD to Present at Investor Healthcare Conferences |
January 29, 2008
BD Announces Results of Shareholder Votes at Annual Meeting |
January 29, 2008
BD Board Declares Dividend |
January 28, 2008
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference |
January 24, 2008
BD Announces Results For First Fiscal Quarter |
January 16, 2008
BD Announces Webcast of Annual Meeting of Shareholders |
January 04, 2008
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call |
January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures |
